Professor Zurab Pagava

Education and Qualifications:

• 1967 – 1973 – State Medical University, Tbilisi (General Medicine);
  
• 1978 – 1983 – Ph.D. program. Miasnikov Institute of Cardiology. Moscow. Russian Federation (Ph.D.);
• 1982 – Radiology. Moscow. Russian Federation.

Certification/Medical License:

• 2001 – Cardiology, Certificate N Ia09-03742;
• 2006 – Internal medicine Certificate N IIIa72-031757;
• 2006 – Sports medicine Certificate N IIa19-27590.

• 1978- 1982 – Department of Rehabilitation and Department of Radionuclide Diagnostic, Russian Institute of Cardiology- Postgraduate and specialist training. Moscow, Russia. Cardiologist;
• 1981-1981 – Medical Radiology and Roentgenology, Moscow, Russia.Radiologist;
• 1982-1988 – Institute of Cardiology, Department of Heart Failure. Senior Scientific Worker;
• 1988 – to present – The scientific research institute of cardiology; Cardiac Rehabilitation Department. Head of department;
• 1998 – to present – Medical Faculty Tbilisi State University, Faculty of Internal Disease. Associate Professor;
• 2005 – to present – The Ltd. “Cito”, Medical Canter; The clinic of Arterial Hypertension and Cardio Vascular Disease. Cardiologist;
• 2008 – to present – Foundation for development of St. George`s cardiological hospital of the Patriarchate of all Georgia.  Scientific consultant;
• 2011-to present – Bokhua Cardiovascular Center. Head of Cardio-Pulmonology Department.

• Member of the European Society of Cardiology

• 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes
• 2018 ESC/ESH Guidelines for the management of arterial hypertension
• 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)
• 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management
• 2011 ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
• ESC Reviewing of congressional abstracts: 2016, 2017, 2018, 2019, 2020

Participated in conferences of the European Society of Cardiology and the USA

EXPERIENCE IN CLINICAL TRIALS:

• 2011 present New Drugs for Plasma Correct Potassium Level in Patients with Arterial Hypertension and DM Chronic Kidney failure II Principal Investigator;
• 2011 present New Drugs for Correct Plasma Potassium Level in Patients with Heart failure and Chronic Kidney failure II Principal Investigator ;
• 2010 present Anti-inflammatory drug with Antilipidemic treatment in patients with ACS III Principal Investigator ;
• 2010 2011 New Drugs for Correct Plasma Potassium Level in Patients with Heart failure and Chronic Kidney failure II Principal Investigator;
• 2009 present Antihypertension treatment in patients with grade II, III hypertension IV Principal Investigator;
• 2008 present Metabolic drug in patients with Stable Angina II Principal Investigator;
• 2008 2010 Anti-inflammatory drug with Antilipidemic treatment in patients with ACS II Principal Investigator;
• 2006 present Diuretic drug in the treatment of CHF with preserved cardiac Function III Investigator;
• 2005 2007 Novel antianginal drug in patients with Non – ST-elevation ACS III Investigator;
• 2004 2006 Novel antianginal drug in patients with Chronic Stable Angina Pectoris III Investigator;
• 2004 2004 Novel antianginal drug in patients with Chronic Angina III Investigator.

Clinical Trials:

• Up to 20 clinical trials

Publications:

• Author of more than 150 publications, including 20 foreign impact journals
  8 Supervisor of doctoral dissertation

Georgian – Native
Russian – Fluent
English – Spoken